COMMUNIQUÉS West-GlobeNewswire

Salarius Pharmaceuticals Successfully Monetizes Legacy Consumer Product
24/07/2019
Completes Sale of HOTSHOT HOUSTON, July 24, 2019 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage oncology company targeting the epigenetic causes of cancers, today announced it [...]
Collegium to Host Conference Call to Discuss Second Quarter 2019 Financial Results and Provide Corporate Update
24/07/2019
STOUGHTON, Mass., July 24, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced today that the Company will host a conference call and live audio webcast on Wednesday, August 7, 2019 at 4:30 [...]
MacroGenics Announces Date of Second Quarter 2019 Financial Results Conference Call
24/07/2019
Rockville, Md., July 24, 2019 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Cara Therapeutics Announces Proposed Offering of Common Stock
24/07/2019
STAMFORD, Conn., July 24, 2019 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate [...]
Gemphire Therapeutics and NeuroBo Pharmaceuticals Announce Merger Agreement to Advance a Neurodegenerative Disease Company
24/07/2019
Transaction to Create Nasdaq-listed Biotechnology Company Focused on Advancing NeuroBo’s Clinical-Stage Pipeline NeuroBo Poised to Advance Lead Drug Candidate into Phase 3 Trials for Neuropathic Pain Indications NeuroBo [...]
Cerner Reports Second Quarter 2019 Results
24/07/2019
All Key Metrics Within or Above Company Guidance Ranges KANSAS CITY, Mo., July 24, 2019 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN) today announced results for the 2019 second quarter that ended June 29, 2019 [...]
Genkyotex Conference Call for Post-Hoc Analysis of Setanaxib (GKT831) PBC Ph2 Trial and Business Update
24/07/2019
ARCHAMPS, France, July 24, 2019 (GLOBE NEWSWIRE) -- Genkyotex (Euronext Paris & Brussels: FR0013399474 – GKTX ) , a biopharmaceutical company and the leader in NOX therapies, will hold a conference call on July 25, [...]
Digirad Corporation to Release 2019 Second Quarter Financial Results on August 6, 2019
24/07/2019
SUWANEE, Ga., July 24, 2019 (GLOBE NEWSWIRE) -- Digirad Corporation (Nasdaq: DRAD) will release financial results for its second quarter ended June 30, 2019 before the market opens on Tuesday, August 6, 2019. A [...]
Prediction of Survival in Patients with Chronic Liver Disease: a Study Confirms the Clinical Benefit of ShearWave Elastography
24/07/2019
Utility of ShearWave Elastography (SWE) in predicting the survival of patients with chronic liver disease has been validated Establishment of a new threshold value for the stratification of the risk of mortality and for [...]
Pluristem Therapeutics’ CEO Issues Shareholders Update
24/07/2019
HAIFA, Israel, July 24, 2019 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI) , a leading regenerative medicine company developing novel placenta-based cell therapy products, today issued an [...]
Zafgen Announces Agreement with U.S. Food and Drug Administration on New Nonclinical Study Design for ZGN-1061
24/07/2019
Alignment reached on in vivo animal study design and protocol to translate work from novel in vitro assays and establish relevant safety margins Topline data from the in vivo study expected by the end of 2019 Company [...]
LifePod®, the First Proactive-Voice Caregiving Service, Honored with 2019 Caregiver Friendly® Award
24/07/2019
Today’s Caregiver magazine award recognizes products, services, books and media created for caregivers’ needs BOSTON , July 24, 2019 (GLOBE NEWSWIRE) -- LifePod Solutions Inc., the groundbreaking, proactive-voice [...]
The Alliance for Regenerative Medicine Releases List of Presenting Companies at the 2019 Cell & Gene Meeting on the Mesa
24/07/2019
WASHINGTON, D.C., July 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization for the cell and gene therapy and broader regenerative [...]
Data on Nadir Testosterone Levels Achieved by ELIGARD® (leuprolide acetate) for injectable suspension published in Reviews in Urology
24/07/2019
CHICAGO, July 24, 2019 (GLOBE NEWSWIRE) -- Tolmar Pharmaceuticals, Inc. today announced the publication of a study of nadir testosterone (T) levels achieved in pivotal trials for ELIGARD ® (leuprolide acetate) for [...]
Alkahest Strengthens Executive Leadership with Appointment of Robert Klein as Chief Business Officer
24/07/2019
SAN CARLOS, Calif., July 24, 2019 (GLOBE NEWSWIRE) -- Alkahest, Inc., a clinical-stage biotechnology company focused on developing innovative therapies to treat age-related diseases, today announced the appointment of [...]
Cognition Therapeutics Extends IP Coverage of Alzheimer’s Therapeutic Elayta™ to Additional Major Pharmaceutical Markets with Patent Issuances in Japan and China
24/07/2019
Pittsburgh, July 24, 2019 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , a clinical stage neuroscience company focused on the protection and restoration of synaptic function in Alzheimer’s disease and other [...]
Rezolute Completes $45 Million Investment Round with Full Exercise of $20 Million Option
24/07/2019
REDWOOD CITY, Calif., July 24, 2019 (GLOBE NEWSWIRE) -- Rezolute, Inc. (“Rezolute”) (OTCQB:RZLT), a clinical stage biopharmaceutical company specializing in the development of transformative therapies targeting [...]
Adamis Pharmaceuticals Provides Update on Litigation with Belcher Pharmaceuticals
24/07/2019
SAN DIEGO, July 24, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) announced today that Adamis and Belcher Pharmaceuticals, LLC (“Belcher”) agreed to settle all previously filed [...]
Obalon Announces Reverse Stock Split Effective Today
24/07/2019
OBLN common stock expected to begin trading on a split-adjusted basis on July 25, 2019 SAN DIEGO, July 24, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology [...]

Pages